We wrap up the year with all the news from our companies
Articles filtered by tag
Mark Baillet – A View from the Biometrics Managing Director’s Office
COVID-19 Vaccines trials …
S-cubed Biometrics’ Mark Baillet: Why Choose Us?
Mark Baillet discusses why S-cubed is a good partner for your trial.
Waving Farewell to 2020 and Looking Forward to 2021
Scott McGregor reflects on 2020 and looks forward to 2021
Lies, Damned Lies & Statistics
Elizabeth Merrall fights for statistical truth!
Supporting Clients using Full Service CROs
Our Biometrics team discuss how S-cubed can help companies that outsource Biometrics activities to a full-service CRO.
Finalised ICH E9(R1) Estimands and Sensitivity Analysis Guidance
We revisit Estimands after it’s adoption in November. Find out how we can help.
Growth, a new office and successful software!
It’s been a fantastic year for S-cubed. Read the reviews from our three managing directors in the UK and Denmark.
Pharmaceutical Industry Events this Autumn
We’re at a number of events between now and the end of November, demonstrating our clinical data expertise. Get in touch if you’d like a meeting.
Protocol writing is changing – Estimands (ICH E9(R1))
This month we explain how S-cubed can assist you in applying the forthcoming regulatory guidance ICH E9(R1)
Statistics and Machine Learning – Cause for concern or excitement?
Statistics and the impact of machine learning get Elizabeth Merrall thinking and considering the future.
Learn more about S-cubed in 2018
With our regulatory, CDISC, and Biometrics teams appearing at various events over the next few months, make sure you meet our experts.